Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT
Status:
Terminated
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine fatigue (tiredness) in subjects with
chronic Rheumatoid Arthritis with chronic anemia. Fatigue in subjects who get PROCRIT will be
compared to fatigue in subjects who get placebo (a medically inactive substance). The study
will also evaluate hemoglobin levels (oxygen-carrying protein in red blood cells), safety,
anemia related health concerns, vitality, arthritis related function and work productivity.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.